Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06106269 · ClinicalTrials.gov registry record
Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
A clinical trial of Internal Hemorrhoid, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06106269: Recruiting study of Internal Hemorrhoid, sponsored by Mayo Clinic.
NCT06106269 is a study of Internal Hemorrhoid that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06106269, a study of Internal Hemorrhoid, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
Primary Outcome
The French bleeding score assesses the intensity of hemorrhoidal bleeding with scores ranging from 0 (no bleeding) to 9 (daily bleeding with anemia requiring blood transfusions)
Conditions Studied
Interventions
- DEVICE Rectal Artery Embolization
Study Locations (1)
Minnesota
- Mayo Clinic Minnesota - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2026-12 |
What NCT06106269 shows while recruiting
NCT06106269 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Internal Hemorrhoid appearing as the primary indexed condition, and to 1 intervention - of which Rectal Artery Embolization is the first listed.
NCT06106269 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06106269 about?
NCT06106269 is a clinical study titled "Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids". This study will assess how effective and safe rectal artery embolization works to treat symptomatic bleeding predominant internal hemorrhoids.
What is the current status of trial NCT06106269?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-06-07. Estimated completion is 2026-12.
What conditions does trial NCT06106269 study?
This clinical trial studies the following conditions: Internal Hemorrhoid.
What interventions are being tested in trial NCT06106269?
The interventions under investigation include: Rectal Artery Embolization (DEVICE).
Who is sponsoring clinical trial NCT06106269?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06106269 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI